Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-023569
Filing Date
2025-09-03
Accepted
2025-09-03 17:02:46
Documents
1
Period of Report
2025-08-29

Document Format Files

Seq Description Document Type Size
1 form4-09032025_090942.html 4  
1 form4-09032025_090942.xml 4 4024
  Complete submission text file 0001415889-25-023569.txt   5446
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Issuer) CIK: 0001746466 (see all company filings)

EIN.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2223 AVENIDA DE LA PLAYA, SUITE 105 LA JOLLA CA 92037
Business Address
Tom Penny (Reporting) CIK: 0002012180 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38692 | Film No.: 251290782